4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-23-045441
CEO and President sold 6,017 shares at an average $1.29 ($7,748)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shukla Sath CEO and President | 2023-08-28 | Sale 10b5-1 | −1,854 | $1.26 | $2,336 | 576,663 | D |
| Shukla Sath CEO and President | 2023-08-29 | Sale 10b5-1 | −4,163 | $1.30 | $5,412 | 572,500 | D |
| Open-market sales · 6,017 sh · avg $1.29 · $7,748 | |||||||
Loading xslF345X05/ownership.xml…